PFE logo

Pfizer (PFE) CAPEX

annual CAPEX:

$2.91B-$998.00M(-25.54%)
December 31, 2024

Summary

  • As of today (June 1, 2025), PFE annual capital expenditures is $2.91 billion, with the most recent change of -$998.00 million (-25.54%) on December 31, 2024.
  • During the last 3 years, PFE annual CAPEX has risen by +$198.00 million (+7.30%).
  • PFE annual CAPEX is now -25.54% below its all-time high of $3.91 billion, reached on December 31, 2023.

Performance

PFE CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

quarterly CAPEX:

$564.00M-$353.00M(-38.50%)
March 29, 2025

Summary

  • As of today (June 1, 2025), PFE quarterly capital expenditures is $564.00 million, with the most recent change of -$353.00 million (-38.50%) on March 29, 2025.
  • Over the past year, PFE quarterly CAPEX has dropped by -$140.00 million (-19.89%).
  • PFE quarterly CAPEX is now -50.48% below its all-time high of $1.14 billion, reached on March 31, 2023.

Performance

PFE quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

TTM CAPEX:

$2.77B-$140.00M(-4.81%)
March 29, 2025

Summary

  • As of today (June 1, 2025), PFE TTM capital expenditures is $2.77 billion, with the most recent change of -$140.00 million (-4.81%) on March 29, 2025.
  • Over the past year, PFE TTM CAPEX has dropped by -$703.00 million (-20.25%).
  • PFE TTM CAPEX is now -29.13% below its all-time high of $3.91 billion, reached on December 31, 2023.

Performance

PFE TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

PFE CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-25.5%-19.9%-20.3%
3 y3 years+7.3%-12.3%-1.1%
5 y5 years+42.2%+25.6%+47.5%

PFE CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-25.5%+7.3%-50.5%at low-29.1%at low
5 y5-year-25.5%+42.2%-50.5%+25.6%-29.1%+74.0%
alltimeall time-25.5%+537.2%-50.5%+448.1%-29.1%+2591.0%

PFE CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$564.00M(-38.5%)
$2.77B(-4.8%)
Dec 2024
$2.91B(-25.5%)
$917.00M(+40.9%)
$2.91B(-4.2%)
Sep 2024
-
$651.00M(+2.2%)
$3.04B(-5.0%)
Jun 2024
-
$637.00M(-9.5%)
$3.19B(-8.0%)
Mar 2024
-
$704.00M(-32.6%)
$3.47B(-11.1%)
Dec 2023
$3.91B(+20.7%)
$1.04B(+28.9%)
$3.91B(+1.1%)
Sep 2023
-
$810.00M(-11.4%)
$3.86B(-0.8%)
Jun 2023
-
$914.00M(-19.8%)
$3.90B(+4.4%)
Mar 2023
-
$1.14B(+13.8%)
$3.73B(+15.3%)
Dec 2022
$3.24B(+19.4%)
$1.00B(+19.0%)
$3.24B(-0.0%)
Sep 2022
-
$841.00M(+12.0%)
$3.24B(+7.4%)
Jun 2022
-
$751.00M(+16.8%)
$3.01B(+7.6%)
Mar 2022
-
$643.00M(-35.8%)
$2.80B(+3.3%)
Dec 2021
$2.71B(+21.8%)
$1.00B(+62.1%)
$2.71B(+7.5%)
Sep 2021
-
$618.00M(+15.1%)
$2.52B(+4.6%)
Jun 2021
-
$537.00M(-3.1%)
$2.41B(+3.4%)
Mar 2021
-
$554.00M(-31.9%)
$2.33B(+4.7%)
Dec 2020
$2.23B(+8.8%)
$813.00M(+60.4%)
$2.23B(+39.9%)
Sep 2020
-
$507.00M(+10.9%)
$1.59B(-8.9%)
Jun 2020
-
$457.00M(+1.8%)
$1.75B(-7.0%)
Mar 2020
-
$449.00M(+152.2%)
$1.88B(-8.3%)
Dec 2019
$2.05B(-4.2%)
$178.00M(-73.1%)
$2.05B(-21.3%)
Sep 2019
-
$662.00M(+12.6%)
$2.60B(+4.0%)
Jun 2019
-
$588.00M(-4.9%)
$2.50B(+7.0%)
Mar 2019
-
$618.00M(-15.6%)
$2.34B(+9.4%)
Dec 2018
$2.14B(-3.7%)
$732.00M(+30.2%)
$2.14B(-1.9%)
Sep 2018
-
$562.00M(+32.5%)
$2.18B(-1.6%)
Jun 2018
-
$424.00M(+1.4%)
$2.21B(-2.9%)
Mar 2018
-
$418.00M(-45.9%)
$2.28B(+2.7%)
Dec 2017
$2.22B(+10.9%)
$773.00M(+29.5%)
$2.22B(+0.2%)
Sep 2017
-
$597.00M(+22.1%)
$2.21B(+8.1%)
Jun 2017
-
$489.00M(+36.6%)
$2.05B(-0.4%)
Mar 2017
-
$358.00M(-53.4%)
$2.06B(+2.9%)
Dec 2016
$2.00B(+33.6%)
$769.00M(+78.0%)
$2.00B(+5.7%)
Sep 2016
-
$432.00M(-13.1%)
$1.89B(+6.0%)
Jun 2016
-
$497.00M(+65.1%)
$1.78B(+15.1%)
Mar 2016
-
$301.00M(-54.5%)
$1.55B(+3.7%)
Dec 2015
$1.50B(-5.5%)
$662.00M(+103.7%)
$1.50B(+21.6%)
Sep 2015
-
$325.00M(+23.6%)
$1.23B(-16.1%)
Jun 2015
-
$263.00M(+6.9%)
$1.47B(-4.2%)
Mar 2015
-
$246.00M(-37.9%)
$1.53B(-3.3%)
Dec 2014
$1.58B(+8.1%)
$396.00M(-29.4%)
$1.58B(-6.1%)
Sep 2014
-
$561.00M(+71.0%)
$1.69B(+16.0%)
Jun 2014
-
$328.00M(+10.1%)
$1.45B(+1.3%)
Mar 2014
-
$298.00M(-40.3%)
$1.44B(-2.0%)
Dec 2013
$1.47B(+3.2%)
$499.00M(+52.1%)
$1.47B(-5.6%)
Sep 2013
-
$328.00M(+5.8%)
$1.55B(+2.8%)
Jun 2013
-
$310.00M(-5.5%)
$1.51B(+1.1%)
Mar 2013
-
$328.00M(-44.0%)
$1.49B(+5.2%)
Dec 2012
$1.42B(-24.6%)
$586.00M(+105.6%)
$1.42B(-14.2%)
Sep 2012
-
$285.00M(-3.1%)
$1.65B(-9.3%)
Jun 2012
-
$294.00M(+15.7%)
$1.82B(-3.4%)
Mar 2012
-
$254.00M(-69.0%)
$1.89B(+0.2%)
Dec 2011
$1.88B(+24.4%)
$820.00M(+80.6%)
$1.88B(+17.0%)
Sep 2011
-
$454.00M(+26.8%)
$1.61B(+11.5%)
Jun 2011
-
$358.00M(+43.2%)
$1.44B(-1.0%)
Mar 2011
-
$250.00M(-54.3%)
$1.46B(-3.6%)
Dec 2010
$1.51B(+25.6%)
$547.00M(+89.9%)
$1.51B(+9.0%)
Sep 2010
-
$288.00M(-22.8%)
$1.39B(+2.0%)
Jun 2010
-
$373.00M(+22.3%)
$1.36B(+8.3%)
Mar 2010
-
$305.00M(-27.7%)
$1.26B(+4.3%)
Dec 2009
$1.21B(-29.2%)
$422.00M(+61.7%)
$1.21B(+2.8%)
Sep 2009
-
$261.00M(-3.0%)
$1.17B(-13.5%)
Jun 2009
-
$269.00M(+6.3%)
$1.35B(-7.9%)
Mar 2009
-
$253.00M(-35.0%)
$1.47B(-13.5%)
Dec 2008
$1.70B(-14.6%)
$389.00M(-12.4%)
$1.70B(-18.4%)
Sep 2008
-
$444.00M(+15.3%)
$2.08B(-0.8%)
Jun 2008
-
$385.00M(-20.3%)
$2.10B(-2.0%)
Mar 2008
-
$483.00M(-37.5%)
$2.15B(+7.7%)
Dec 2007
$1.99B
$773.00M(+67.7%)
$1.99B(+0.4%)
Sep 2007
-
$461.00M(+7.7%)
$1.98B(-4.3%)
DateAnnualQuarterlyTTM
Jun 2007
-
$428.00M(+30.1%)
$2.07B(-1.9%)
Mar 2007
-
$329.00M(-57.0%)
$2.11B(-4.0%)
Dec 2006
$2.20B(+4.6%)
$765.00M(+38.8%)
$2.20B(+7.4%)
Sep 2006
-
$551.00M(+17.5%)
$2.05B(+2.8%)
Jun 2006
-
$469.00M(+12.2%)
$2.00B(-3.1%)
Mar 2006
-
$418.00M(-31.8%)
$2.06B(-2.2%)
Dec 2005
$2.11B(-19.0%)
$613.00M(+23.6%)
$2.11B(-18.0%)
Sep 2005
-
$496.00M(-6.8%)
$2.57B(-2.6%)
Jun 2005
-
$532.00M(+14.4%)
$2.64B(+1.7%)
Mar 2005
-
$465.00M(-56.7%)
$2.59B(-0.3%)
Dec 2004
$2.60B(-1.1%)
$1.07B(+90.3%)
$2.60B(+13.4%)
Sep 2004
-
$565.00M(+15.5%)
$2.29B(-3.9%)
Jun 2004
-
$489.00M(+3.6%)
$2.39B(-12.2%)
Mar 2004
-
$472.00M(-38.5%)
$2.72B(+3.4%)
Dec 2003
$2.63B(+49.5%)
$767.00M(+16.6%)
$2.63B(+7.4%)
Sep 2003
-
$658.00M(-20.0%)
$2.45B(+13.3%)
Jun 2003
-
$822.00M(+115.2%)
$2.16B(+22.0%)
Mar 2003
-
$382.00M(-34.8%)
$1.77B(+0.7%)
Dec 2002
$1.76B(-16.5%)
$586.00M(+58.0%)
$1.76B(0.0%)
Sep 2002
-
$371.00M(-14.1%)
$1.76B(-8.8%)
Jun 2002
-
$432.00M(+17.1%)
$1.93B(-5.7%)
Mar 2002
-
$369.00M(-37.0%)
$2.04B(-2.9%)
Dec 2001
$2.10B(-3.9%)
$586.00M(+8.5%)
$2.10B(+3.0%)
Sep 2001
-
$540.00M(-1.6%)
$2.04B(-3.9%)
Jun 2001
-
$549.00M(+27.7%)
$2.13B(-1.8%)
Mar 2001
-
$430.00M(-17.9%)
$2.17B(-1.1%)
Dec 2000
$2.19B(-12.1%)
$524.00M(-16.0%)
$2.19B(+3.2%)
Sep 2000
-
$624.00M(+5.9%)
$2.12B(-12.7%)
Jun 2000
-
$589.00M(+29.7%)
$2.43B(-6.2%)
Mar 2000
-
$454.00M(-0.7%)
$2.60B(+4.1%)
Dec 1999
$2.49B(+27.8%)
$457.00M(-51.0%)
$2.49B(-21.5%)
Sep 1999
-
$933.00M(+24.2%)
$3.17B(+22.4%)
Jun 1999
-
$751.00M(+113.4%)
$2.59B(+22.7%)
Mar 1999
-
$352.00M(-69.1%)
$2.11B(+8.3%)
Dec 1998
$1.95B(+122.2%)
$1.14B(+223.3%)
$1.95B(+79.5%)
Sep 1998
-
$352.00M(+29.9%)
$1.09B(+18.3%)
Jun 1998
-
$271.00M(+42.6%)
$919.00M(+7.2%)
Mar 1998
-
$190.00M(-30.7%)
$857.00M(-2.4%)
Dec 1997
$878.00M(-23.0%)
$274.00M(+48.9%)
$878.00M(-28.9%)
Sep 1997
-
$184.00M(-12.0%)
$1.24B(-1.0%)
Jun 1997
-
$209.00M(-0.9%)
$1.25B(+2.5%)
Mar 1997
-
$211.00M(-66.6%)
$1.22B(+6.7%)
Dec 1996
$1.14B(+63.9%)
$631.00M(+220.3%)
$1.14B(+60.0%)
Sep 1996
-
$197.00M(+10.7%)
$713.10M(+2.8%)
Jun 1996
-
$178.00M(+31.9%)
$693.60M(+9.2%)
Mar 1996
-
$135.00M(-33.5%)
$634.90M(-8.8%)
Dec 1995
$696.30M(+3.7%)
$203.10M(+14.4%)
$696.30M(+1.4%)
Sep 1995
-
$177.50M(+48.8%)
$686.90M(-1.6%)
Jun 1995
-
$119.30M(-39.3%)
$698.10M(-5.6%)
Mar 1995
-
$196.40M(+1.4%)
$739.70M(+10.2%)
Dec 1994
$671.50M(+5.9%)
$193.70M(+2.6%)
$671.50M(-1.5%)
Sep 1994
-
$188.70M(+17.3%)
$681.50M(+7.1%)
Jun 1994
-
$160.90M(+25.5%)
$636.60M(+0.6%)
Mar 1994
-
$128.20M(-37.1%)
$632.60M(-0.3%)
Dec 1993
$634.20M(-5.9%)
$203.70M(+41.7%)
$634.20M(-2.8%)
Sep 1993
-
$143.80M(-8.3%)
$652.60M(-4.7%)
Jun 1993
-
$156.90M(+20.9%)
$685.10M(+0.9%)
Mar 1993
-
$129.80M(-41.6%)
$679.00M(+0.7%)
Dec 1992
$674.20M(+13.5%)
$222.10M(+26.0%)
$674.20M(+5.7%)
Sep 1992
-
$176.30M(+16.9%)
$637.60M(+3.9%)
Jun 1992
-
$150.80M(+20.6%)
$613.70M(+1.8%)
Mar 1992
-
$125.00M(-32.6%)
$602.90M(+1.5%)
Dec 1991
$593.80M(+8.5%)
$185.50M(+21.7%)
$593.80M(+5.5%)
Sep 1991
-
$152.40M(+8.9%)
$562.90M(-0.2%)
Jun 1991
-
$140.00M(+20.8%)
$564.00M(+0.6%)
Mar 1991
-
$115.90M(-25.0%)
$560.50M(+2.4%)
Dec 1990
$547.50M(+19.9%)
$154.60M(+0.7%)
$547.50M(+39.3%)
Sep 1990
-
$153.50M(+12.5%)
$392.90M(+64.1%)
Jun 1990
-
$136.50M(+32.7%)
$239.40M(+132.7%)
Mar 1990
-
$102.90M
$102.90M
Dec 1989
$456.50M
-
-

FAQ

  • What is Pfizer annual capital expenditures?
  • What is the all time high annual CAPEX for Pfizer?
  • What is Pfizer annual CAPEX year-on-year change?
  • What is Pfizer quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Pfizer?
  • What is Pfizer quarterly CAPEX year-on-year change?
  • What is Pfizer TTM capital expenditures?
  • What is the all time high TTM CAPEX for Pfizer?
  • What is Pfizer TTM CAPEX year-on-year change?

What is Pfizer annual capital expenditures?

The current annual CAPEX of PFE is $2.91B

What is the all time high annual CAPEX for Pfizer?

Pfizer all-time high annual capital expenditures is $3.91B

What is Pfizer annual CAPEX year-on-year change?

Over the past year, PFE annual capital expenditures has changed by -$998.00M (-25.54%)

What is Pfizer quarterly capital expenditures?

The current quarterly CAPEX of PFE is $564.00M

What is the all time high quarterly CAPEX for Pfizer?

Pfizer all-time high quarterly capital expenditures is $1.14B

What is Pfizer quarterly CAPEX year-on-year change?

Over the past year, PFE quarterly capital expenditures has changed by -$140.00M (-19.89%)

What is Pfizer TTM capital expenditures?

The current TTM CAPEX of PFE is $2.77B

What is the all time high TTM CAPEX for Pfizer?

Pfizer all-time high TTM capital expenditures is $3.91B

What is Pfizer TTM CAPEX year-on-year change?

Over the past year, PFE TTM capital expenditures has changed by -$703.00M (-20.25%)
On this page